Sarfatii Gadi,Lovinger Ioana,Licht Danit,Safadi Muhammad
申请号：
NZ63024113
公开号：
NZ630241A
申请日:
2013.07.10
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Disclosed is a stable pharmaceutical composition comprising a therapeutically effective amount of laquinimod, an amount of a filler, and an amount of a lubricant, wherein the stable pharmaceutical composition is free of an alkalizing agent or an oxidation reducing agent. Also disclosed is a process for making the stable pharmaceutical composition and sealed packages comprising the stable pharmaceutical composition and the use of a stable pharmaceutical composition for treating a subject afflicted with a form of multiple sclerosis.
